Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles
Stretch Mark Cream

Obama Nominates Human Genome Veteran To Lead NIH
Dr. Francis S. Collins, the Yale-educated, guitar-strumming physician and geneticist who led the Human Genome Project, was nominated Wednesday to head the National Institutes of Health, the New York Times reports. "Dr. Collins"s selection, which had been rumored for weeks, was praised by top scientists and research advocacy organizations for whom the health institute is a crucial patron," the Times reports. He is expected to sail through Senate confirmation.
generic viagra online
UCLA Scientists Identify How Immune Cells May Help Predict Alzheimer's Risk; MP Biomedicals Granted Rights To Further Develop Screening Tool
UCLA scientists have discovered a way to measure the amount of amyloid beta that is being absorbed by immune cells in the blood. Amyloid beta forms the plaques considered the hallmark of Alzheimer"s disease, and if the immune system isn"t adequately clearing amyloid beta, it may indicate Alzheimer"s risk, according to the researchers. Drugshop to buy zoloft online and other pills.
News of the day
Joseph P. Vande Griend Receives 2009 APhA Clinical Research Paper Award
The American Pharmacists Association (APhA) is pleased to announce that Joseph P. Vande Griend, PharmD, BCPS, of Denver, Colorado, is the recipient of the 2009 APhA Clinical Research Paper Award. The award was presented during the APhA Annual Meeting and Exposition in San Antonio, Texas, April 3-6, 2009.
Mental Health

Merck Partners With Non-Profit For Neglected Diseases Initiative

The pharmaceutical company, Merck, announced Monday it was partnering with the non-profit Drugs for Neglected Diseases initiative (DNDi) in an effort to improve treatments for neglected tropical diseases (NTD), the AP/CNBC reports. "The agreement covers drug candidates for illnesses like visceral leishmaniasis and Chagas disease, potentially lethal parasitic illnesses spread by insects. Current treatment for those illnesses may be toxic, or very expensive, or difficult to administer, Merck said," AP/CNBC writes (AP/CNBC, 6/22). RTT News reports, "Under terms of the agreement, Merck will contribute small molecule assets and related intellectual property via a non-exclusive, royalty-free license to DNDi to conduct early development programs for drug candidates for the treatment of NTDs like visceral leishmaniasis and Chagas disease" (RTT News, 6/22). In related news, Xinhua/CRIENGLISH.com reports on an international NTD meeting to be held Tuesday in Nairobi, Kenya. The meeting - sponsored by DNDi - will bring together researchers, clinicians and policymakers from around the world to discuss the latest research and drug development for NTD. "The meeting will also cement DNDi"s partnership with key players such as NGOs and leading African and international experts on infectious and neglected tropical diseases, according to Dr. Monique Wasunna, the assistant director," the news agency reports (Xinhua/CRIENGLISH.com, 6/22). This information was reprinted from globalhealth.kff.org with kind permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily Global Health Policy Report, search the archives and sign up for email delivery at globalhealth.kff.org. © Henry J. Kaiser Family Foundation. All rights reserved.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009